Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-73P is a pseudogene belonging to the U1 small nuclear RNA (snRNA) family. Unlike canonical U1 snRNA genes such as RNU1-1, which are essential for pre-mRNA splicing, RNU1-73P does not produce a functional snRNA product and does not participate in known cellular processes. The presence of this pseudogene results from duplication and mutation events in the genome and serves mainly as a genomic record of gene family expansion. There is no evidence of a biological function, disease association, or therapeutic relevance for RNU1-73P. The U1 small nuclear RNA family is involved in RNA splicing, but RNU1-73P, as a pseudogene, does not perform this function. No data supports any interaction with drugs, role in disease, or use as a biomarker. RNU1-73P may mistakenly appear in target lists owing to confusion with functional snRNA genes or incomplete annotations. For structured data, RNU1-73P should be flagged as non-target and incorrect if included as a receptor or therapeutic protein. The canonical name and abbreviation are correct for identification, but this entity is not suitable for drug targeting or clinical biomarker studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 73, pseudogene (RNU1-73P).